Global Low-dose Birth Control Pill 麻豆原创 Growth 2025-2031

Publication ID:

LPI02256282

Publication Date:

February 28, 2025

Pages:

142

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Low-dose Birth Control Pill market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淟ow-dose Birth Control Pill Industry Forecast鈥� looks at past sales and reviews total world Low-dose Birth Control Pill sales in 2024, providing a comprehensive analysis by region and market sector of projected Low-dose Birth Control Pill sales for 2025 through 2031. With Low-dose Birth Control Pill sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Low-dose Birth Control Pill industry.
This Insight Report provides a comprehensive analysis of the global Low-dose Birth Control Pill landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Low-dose Birth Control Pill portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Low-dose Birth Control Pill market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Low-dose Birth Control Pill and breaks down the forecast by Type, by Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Low-dose Birth Control Pill.
This report presents a comprehensive overview, market shares, and growth opportunities of Low-dose Birth Control Pill market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Ethinyl Estradiol
Drospirenone
Levonorgestrel
Norethindrone
Others
Segmentation by Channel:
Offline Sales
Online Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Lo Loestrin
Slynd
Balcoltra
Nextstellis
Taytulla
Bayer
Phexxi
Viatris
Tyblume
Twirla
Xulane
Alloy
Pfizer
Organon
Janssen
AbbVie
Teva Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Low-dose Birth Control Pill market?
What factors are driving Low-dose Birth Control Pill market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Low-dose Birth Control Pill market opportunities vary by end market size?
How does Low-dose Birth Control Pill break out by Type, by Channel?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Low-dose Birth Control Pill Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Low-dose Birth Control Pill by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Low-dose Birth Control Pill by Country/Region, 2020, 2024 & 2031
2.2 Low-dose Birth Control Pill Segment by Type
2.2.1 Ethinyl Estradiol
2.2.2 Drospirenone
2.2.3 Levonorgestrel
2.2.4 Norethindrone
2.2.5 Others
2.3 Low-dose Birth Control Pill Sales by Type
2.3.1 Global Low-dose Birth Control Pill Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Low-dose Birth Control Pill Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Low-dose Birth Control Pill Sale Price by Type (2020-2025)
2.4 Low-dose Birth Control Pill Segment by Channel
2.4.1 Offline Sales
2.4.2 Online Sales
2.5 Low-dose Birth Control Pill Sales by Channel
2.5.1 Global Low-dose Birth Control Pill Sale 麻豆原创 Share by Channel (2020-2025)
2.5.2 Global Low-dose Birth Control Pill Revenue and 麻豆原创 Share by Channel (2020-2025)
2.5.3 Global Low-dose Birth Control Pill Sale Price by Channel (2020-2025)
3 Global by Company
3.1 Global Low-dose Birth Control Pill Breakdown Data by Company
3.1.1 Global Low-dose Birth Control Pill Annual Sales by Company (2020-2025)
3.1.2 Global Low-dose Birth Control Pill Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Low-dose Birth Control Pill Annual Revenue by Company (2020-2025)
3.2.1 Global Low-dose Birth Control Pill Revenue by Company (2020-2025)
3.2.2 Global Low-dose Birth Control Pill Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Low-dose Birth Control Pill Sale Price by Company
3.4 Key Manufacturers Low-dose Birth Control Pill Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Low-dose Birth Control Pill Product Location Distribution
3.4.2 Players Low-dose Birth Control Pill Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Low-dose Birth Control Pill by Geographic Region
4.1 World Historic Low-dose Birth Control Pill 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Low-dose Birth Control Pill Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Low-dose Birth Control Pill Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Low-dose Birth Control Pill 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Low-dose Birth Control Pill Annual Sales by Country/Region (2020-2025)
4.2.2 Global Low-dose Birth Control Pill Annual Revenue by Country/Region (2020-2025)
4.3 Americas Low-dose Birth Control Pill Sales Growth
4.4 APAC Low-dose Birth Control Pill Sales Growth
4.5 Europe Low-dose Birth Control Pill Sales Growth
4.6 Middle East & Africa Low-dose Birth Control Pill Sales Growth
5 Americas
5.1 Americas Low-dose Birth Control Pill Sales by Country
5.1.1 Americas Low-dose Birth Control Pill Sales by Country (2020-2025)
5.1.2 Americas Low-dose Birth Control Pill Revenue by Country (2020-2025)
5.2 Americas Low-dose Birth Control Pill Sales by Type (2020-2025)
5.3 Americas Low-dose Birth Control Pill Sales by Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Low-dose Birth Control Pill Sales by Region
6.1.1 APAC Low-dose Birth Control Pill Sales by Region (2020-2025)
6.1.2 APAC Low-dose Birth Control Pill Revenue by Region (2020-2025)
6.2 APAC Low-dose Birth Control Pill Sales by Type (2020-2025)
6.3 APAC Low-dose Birth Control Pill Sales by Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Low-dose Birth Control Pill by Country
7.1.1 Europe Low-dose Birth Control Pill Sales by Country (2020-2025)
7.1.2 Europe Low-dose Birth Control Pill Revenue by Country (2020-2025)
7.2 Europe Low-dose Birth Control Pill Sales by Type (2020-2025)
7.3 Europe Low-dose Birth Control Pill Sales by Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Low-dose Birth Control Pill by Country
8.1.1 Middle East & Africa Low-dose Birth Control Pill Sales by Country (2020-2025)
8.1.2 Middle East & Africa Low-dose Birth Control Pill Revenue by Country (2020-2025)
8.2 Middle East & Africa Low-dose Birth Control Pill Sales by Type (2020-2025)
8.3 Middle East & Africa Low-dose Birth Control Pill Sales by Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Low-dose Birth Control Pill
10.3 Manufacturing Process Analysis of Low-dose Birth Control Pill
10.4 Industry Chain Structure of Low-dose Birth Control Pill
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Low-dose Birth Control Pill Distributors
11.3 Low-dose Birth Control Pill Customer
12 World Forecast Review for Low-dose Birth Control Pill by Geographic Region
12.1 Global Low-dose Birth Control Pill 麻豆原创 Size Forecast by Region
12.1.1 Global Low-dose Birth Control Pill Forecast by Region (2026-2031)
12.1.2 Global Low-dose Birth Control Pill Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Low-dose Birth Control Pill Forecast by Type (2026-2031)
12.7 Global Low-dose Birth Control Pill Forecast by Channel (2026-2031)
13 Key Players Analysis
13.1 Lo Loestrin
13.1.1 Lo Loestrin Company Information
13.1.2 Lo Loestrin Low-dose Birth Control Pill Product Portfolios and Specifications
13.1.3 Lo Loestrin Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Lo Loestrin Main Business Overview
13.1.5 Lo Loestrin Latest Developments
13.2 Slynd
13.2.1 Slynd Company Information
13.2.2 Slynd Low-dose Birth Control Pill Product Portfolios and Specifications
13.2.3 Slynd Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Slynd Main Business Overview
13.2.5 Slynd Latest Developments
13.3 Balcoltra
13.3.1 Balcoltra Company Information
13.3.2 Balcoltra Low-dose Birth Control Pill Product Portfolios and Specifications
13.3.3 Balcoltra Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Balcoltra Main Business Overview
13.3.5 Balcoltra Latest Developments
13.4 Nextstellis
13.4.1 Nextstellis Company Information
13.4.2 Nextstellis Low-dose Birth Control Pill Product Portfolios and Specifications
13.4.3 Nextstellis Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Nextstellis Main Business Overview
13.4.5 Nextstellis Latest Developments
13.5 Taytulla
13.5.1 Taytulla Company Information
13.5.2 Taytulla Low-dose Birth Control Pill Product Portfolios and Specifications
13.5.3 Taytulla Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Taytulla Main Business Overview
13.5.5 Taytulla Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer Low-dose Birth Control Pill Product Portfolios and Specifications
13.6.3 Bayer Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Phexxi
13.7.1 Phexxi Company Information
13.7.2 Phexxi Low-dose Birth Control Pill Product Portfolios and Specifications
13.7.3 Phexxi Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Phexxi Main Business Overview
13.7.5 Phexxi Latest Developments
13.8 Viatris
13.8.1 Viatris Company Information
13.8.2 Viatris Low-dose Birth Control Pill Product Portfolios and Specifications
13.8.3 Viatris Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Viatris Main Business Overview
13.8.5 Viatris Latest Developments
13.9 Tyblume
13.9.1 Tyblume Company Information
13.9.2 Tyblume Low-dose Birth Control Pill Product Portfolios and Specifications
13.9.3 Tyblume Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Tyblume Main Business Overview
13.9.5 Tyblume Latest Developments
13.10 Twirla
13.10.1 Twirla Company Information
13.10.2 Twirla Low-dose Birth Control Pill Product Portfolios and Specifications
13.10.3 Twirla Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Twirla Main Business Overview
13.10.5 Twirla Latest Developments
13.11 Xulane
13.11.1 Xulane Company Information
13.11.2 Xulane Low-dose Birth Control Pill Product Portfolios and Specifications
13.11.3 Xulane Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Xulane Main Business Overview
13.11.5 Xulane Latest Developments
13.12 Alloy
13.12.1 Alloy Company Information
13.12.2 Alloy Low-dose Birth Control Pill Product Portfolios and Specifications
13.12.3 Alloy Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Alloy Main Business Overview
13.12.5 Alloy Latest Developments
13.13 Pfizer
13.13.1 Pfizer Company Information
13.13.2 Pfizer Low-dose Birth Control Pill Product Portfolios and Specifications
13.13.3 Pfizer Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Pfizer Main Business Overview
13.13.5 Pfizer Latest Developments
13.14 Organon
13.14.1 Organon Company Information
13.14.2 Organon Low-dose Birth Control Pill Product Portfolios and Specifications
13.14.3 Organon Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Organon Main Business Overview
13.14.5 Organon Latest Developments
13.15 Janssen
13.15.1 Janssen Company Information
13.15.2 Janssen Low-dose Birth Control Pill Product Portfolios and Specifications
13.15.3 Janssen Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Janssen Main Business Overview
13.15.5 Janssen Latest Developments
13.16 AbbVie
13.16.1 AbbVie Company Information
13.16.2 AbbVie Low-dose Birth Control Pill Product Portfolios and Specifications
13.16.3 AbbVie Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 AbbVie Main Business Overview
13.16.5 AbbVie Latest Developments
13.17 Teva Pharmaceutical
13.17.1 Teva Pharmaceutical Company Information
13.17.2 Teva Pharmaceutical Low-dose Birth Control Pill Product Portfolios and Specifications
13.17.3 Teva Pharmaceutical Low-dose Birth Control Pill Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Teva Pharmaceutical Main Business Overview
13.17.5 Teva Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.